We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
-1.32%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$417M
AUM Growth
-$24.5M
(-5.6%)
Cap. Flow
-$15.1M
Cap. Flow
% of AUM
-3.63%
Top 10 Holdings %
Top 10 Hldgs %
23.16%
Holding
1,096
New
51
Increased
294
Reduced
328
Closed
50
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$7.46M |
| 2 |
Linde
LIN
|
+$6.13M |
| 3 |
Logitech
LOGI
|
+$3.75M |
| 4 |
Coca-Cola
KO
|
+$1.49M |
| 5 |
Amazon
AMZN
|
+$990K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stellantis
STLA
|
+$14.3M |
| 2 |
iShares S&P 500 Value ETF
IVE
|
+$7.54M |
| 3 |
Alcon
ALC
|
+$5.41M |
| 4 |
Ferrari
RACE
|
+$5.16M |
| 5 |
CNH
CNH Industrial
CNH
|
+$2.87M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.48% |
| 2 | Technology | 15.28% |
| 3 | Consumer Discretionary | 11.12% |
| 4 | Healthcare | 10.96% |
| 5 | Industrials | 9.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
CareDx
CDNA
$1.88B
| $120K | 0.03% |
1,888
+253
| +15% | +$19.3K |
|
502
Incyte
INCY
$23.7B
| $119K | 0.03% |
1,724
+124
| +8% | +$9.42K |
|
503
Zai Lab
ZLAB
$2.1B
| $115K | 0.03% |
1,091
+306
| +39% | +$43.9K |
|
504
Iron Mountain
IRM
$37.8B
| $114K | 0.03% |
2,630
+1,767
| +205% | +$79.5K |
|
505
AllianceBernstein
AB
$3.54B
| $114K | 0.03% |
+2,290
| New | +$113K |
|
|
ONC
506
BeOne Medicines Ltd
ONC
$33.8B
| $113K | 0.03% |
311
+72
| +30% | +$23.5K |
|
507
Cooper Companies
COO
$13.7B
| $112K | 0.03% |
1,084
-328
| -23% | -$35K |
|
508
Zions Bancorporation
ZION
$10B
| $111K | 0.03% |
1,799
+683
| +61% | +$37.5K |
|
|
NREF
509
NexPoint Real Estate Finance
NREF
$318M
| $111K | 0.03% |
5,680
-2,120
| -27% | -$43.9K |
|
510
Electronic Arts
EA
$52.4B
| $110K | 0.03% |
776
-608
| -44% | -$85.3K |
|
511
Stryker
SYK
$129B
| $110K | 0.03% |
418
-131
| -24% | -$35K |
|
512
Asana
ASAN
$1.79B
| $109K | 0.03% |
+1,048
| New | +$87K |
|
|
PPLT
513
abrdn Physical Platinum Shares ETF
PPLT
$1.85B
| $107K | 0.03% |
11,910
| – | – |
|
514
Calix
CALX
$2.32B
| $107K | 0.03% |
2,169
+145
| +7% | +$6.69K |
|
515
CALL
Corsair Gaming
CRSR
$1.13B
| $107K | 0.03% |
+1,025
| New | +$29.4K |
|
516
Illumina
ILMN
$28.7B
| $107K | 0.03% |
271
-81
| -23% | -$37.3K |
|
517
BridgeBio Pharma
BBIO
$16.5B
| $105K | 0.03% |
2,247
-321
| -13% | -$17.2K |
|
518
Biogen
BIIB
$29.5B
| $105K | 0.03% |
370
+369
| +36,900% | +$121K |
|
519
CRISPR Therapeutics
CRSP
$4.6B
| $103K | 0.02% |
920
+270
| +42% | +$33.9K |
|
520
iShares 7-10 Year Treasury Bond ETF
IEF
$47.3B
| $103K | 0.02% |
893
-1,000
| -53% | -$117K |
|
|
VMW
521
DELISTED
VMware, Inc
VMW
| $102K | 0.02% |
686
-88
| -11% | -$13.3K |
|
522
Nuveen Credit Strategies Income Fund
JQC
$702M
| $102K | 0.02% |
15,500
| – | – |
|
523
Emergent Biosolutions
EBS
$378M
| $101K | 0.02% |
2,024
-333
| -14% | -$20.2K |
|
524
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.16B
| $101K | 0.02% |
1,291
-169
| -12% | -$13.5K |
|
525
Palantir
PLTR
$315B
| $99.2K | 0.02% |
4,127
| – | – |
|
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q3 2021 Portfolio in Review
As of Q3 2021, Exane Derivatives held 1,096 positions worth $417M, down 5.6% from $441M the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Exane Derivatives withdrew a net $15.1M in Q3 2021, closing 50 positions and reducing 328 holdings. Its most notable exit was Kraft Heinz, an estimated $1.62M position sold in full.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 13% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Exane Derivatives opened a new position in Discovery, Inc. Series C Common Stock worth $796K.
- Exane Derivatives's largest Q3 2021 buy was Discovery, Inc. Series C Common Stock: 32,809 shares worth $796K.
- Exane Derivatives added most to UBS Group in Q3 2021, an estimated $7.46M increase.
- Exane Derivatives's biggest Q3 2021 reduction was Stellantis, cutting an estimated $14.3M.
- Exane Derivatives fully exited Kraft Heinz in Q3 2021, selling an estimated $1.62M.
- Exane Derivatives's ten largest holdings make up 23% of its $417M portfolio in Q3 2021.
- Exane Derivatives opened 51 new positions and closed 50 in Q3 2021.
- Exane Derivatives's portfolio value fell 5.6% quarter-over-quarter to $417M.
Based on Exane Derivatives's 13F filing for Q3 2021, filed 26 Oct 2021.